• Blog
  • Glucose Monitoring System Market Report

    Glucose Monitoring System Market Report

    Glucose Monitoring System Market Report
    Report code - SR1541 Delivery - 2 Weeks
    Get Free Sample |
    Glucose Monitoring System Market Trends, Dynamcis & Market Insights
    See more...

    Market Insights

    The Glucose Monitoring System market is projected to grow from USD 1.9 billion in 2020 to USD 2.7 billion by 2026 at a CAGR of around 6.1% during the forecast period.

    Figure: Glucose Monitoring System Market Size, 2020-2026 (USD Billion)

    Glucose-Monitoring-System-Market-Forecast

    Wish to get a free sample? Register Here

    What are glucose monitoring systems?

    Glucose monitoring systems are used to checking of blood sugar levels. It helps tracks blood sugar levels throughout the day and night. It helps to make better choices about food, physical activities and taking medicines. It also helps find trends and patterns which can help the healthcare provider better manage diabetes. Based on type, glucose monitoring systems can be categorized as sensors, transmitters & receivers, and integrated insulin pumps.

    Key Players

    Key players operating in the Glucose Monitoring System market are-

    • Medtronic plc (Ireland)
    • Abbott Laboratories (US)
    • DexCom, Inc. (US)
    • Echo Therapeutics Inc. (US)
    • Insulet Corporation (US)
    • Johnson & Johnson (US)
    • Senseonics Holdings, Inc. (US)
    • F. Hoffmann-La Roche AG (Switzerland)
    • AgaMatrix Inc. (Germany)
    • Glysure Ltd (UK)
    • ORSENSE LTD (Israel)
    • Ypsomed (Switzerland)

    Market Dynamics

    The growth of the glucose monitoring system market is primarily driven by an increasing number of people suffering from diabetes. The rising prevalence of chronic disease owing to changing lifestyles and unhealthy eating habits is expected to propel the market growth at a significant rate during the review period. Additionally, growing emphasis on research and development activities to develop advanced glucose monitoring systems is likely to create lucrative opportunities for the market players during the review period.

    Segments' Analysis

    End-User Trends

    By end-user, the glucose monitoring system market has been bifurcated into hospitals, clinics, and home healthcare. Under these, the hospitals' segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure, technical expertise, and professional healthcare staff.

    Regional Trends

    By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to expanding geriatric populace and rising incidences of diabetes coupled with the presence of key market players such as Echo Therapeutics Inc. (US) and Insulet Corporation (US). The market growth in the Asia-Pacific region is expected to be driven by the increasing number of people having diabetes due to a sedentary lifestyle in developing countries, particularly China and India.

    COVID-19 Impact on Glucose Monitoring System Market

    The outbreak of the COVID-19 virus has affected the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply for a short period and thus, affected the market growth.

    Critical Questions Answered in the Report

    • What are the key trends in the Glucose Monitoring System market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the Glucose Monitoring System market?
    • What are the key strategies adopted by the major vendors to lead in the Glucose Monitoring System market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the glucose monitoring system market hopes to have the greatest opportunity to convert-

    • Glucose monitoring system distributors
    • Glucose monitoring system suppliers
    • Glucose monitoring system manufacturers
    • Logistics organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The glucose monitoring system market is expected to witness an impressive growth of 6.1% CAGR in the coming years.

    Medtronic plc (Ireland), Abbott Laboratories (US), DexCom, Inc. (US), Echo Therapeutics Inc. (US), Insulet Corporation (US), Johnson & Johnson (US), Senseonics Holdings, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), AgaMatrix Inc. (Germany), Glysure Ltd (UK), ORSENSE LTD (Israel) and Ypsomed (Switzerland) are among the key players in the glucose monitoring system market.

    The glucose monitoring system market size is expected to reach USD 2.7 billion in the foreseeable future.

    The hospitals' segment is expected to register significant growth in the glucose monitoring system market in the coming years.

    North America accounted for the largest share in the glucose monitoring system market in the coming years.

    Glucose monitoring system distributors, Glucose monitoring system suppliers, Glucose monitoring system manufacturers, Logistics organizations, Government bodies are the target audience in the glucose monitoring system market.